These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14748200)

  • 61. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
    Leyden J; Lowe N; Kakita L; Draelos Z
    Cutis; 2001 Jun; 67(6 Suppl):10-6. PubMed ID: 11499327
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.
    Scher RK; Stiller M; Zhu YI
    Cutis; 2001 Nov; 68(5):355-8. PubMed ID: 11766122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimising the use of tazarotene in clinical practice: consensus statement from the European advisory panel for tazarotene (Zorac TM).
    Gollnick HP; Finzi AF; Marks R; Barker JN; Jansen C; Revuz J; Saurat J
    Dermatology; 1999; 199(1):40-6. PubMed ID: 10449956
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel.
    Sefton J; Kligman AM; Kopper SC; Lue JC; Gibson JR
    J Am Acad Dermatol; 2000 Oct; 43(4):656-63. PubMed ID: 11004622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.
    Gollnick H; Menter A
    Br J Dermatol; 1999 Apr; 140 Suppl 54():18-23. PubMed ID: 10731130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
    Dando TM; Wellington K
    Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Receptor-selective retinoids for psoriasis: focus on tazarotene.
    Weindl G; Roeder A; Schäfer-Korting M; Schaller M; Korting HC
    Am J Clin Dermatol; 2006; 7(2):85-97. PubMed ID: 16605289
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.
    Weinstein GD; Krueger GG; Lowe NJ; Duvic M; Friedman DJ; Jegasothy BV; Jorizzo JL; Shmunes E; Tschen EH; Lew-Kaya DA; Lue JC; Sefton J; Gibson JR; Chandraratna RA
    J Am Acad Dermatol; 1997 Jul; 37(1):85-92. PubMed ID: 9216528
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of tazarotene on ichthyosiform erythroderma of Tay's syndrome.
    Varghese VS; Rai R; Sundaram SV; Prabhu KS; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2007; 73(2):126-7. PubMed ID: 17456926
    [No Abstract]   [Full Text] [Related]  

  • 72. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
    Phillips TJ; Gottlieb AB; Leyden JJ; Lowe NJ; Lew-Kaya DA; Sefton J; Walker PS; Gibson JR;
    Arch Dermatol; 2002 Nov; 138(11):1486-93. PubMed ID: 12437455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
    J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Developments in topical retinoid therapy for acne.
    Bershad S
    Semin Cutan Med Surg; 2001 Sep; 20(3):154-61. PubMed ID: 11594670
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interactions between tazarotene and ultraviolet light.
    Hecker D; Worsley J; Yueh G; Kuroda K; Lebwohl M
    J Am Acad Dermatol; 1999 Dec; 41(6):927-30. PubMed ID: 10570375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment.
    Fischer-Levancini C; Sánchez-Regaña M; Llambí F; Collgros H; Expósito-Serrano V; Umbert-Millet P
    Actas Dermosifiliogr; 2012 Oct; 103(8):725-8. PubMed ID: 22818395
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
    Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
    J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New topicals for mild and moderate psoriasis.
    Cooper CW
    JAAPA; 1999 Apr; 12(4):52-4, 57-60. PubMed ID: 10728082
    [No Abstract]   [Full Text] [Related]  

  • 80. Tazarotene foam versus tazarotene gel: a randomized relative bioavailability study in acne vulgaris.
    Jarratt M; Werner CP; Alió Saenz AB
    Clin Drug Investig; 2013 Apr; 33(4):283-9. PubMed ID: 23456673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.